cilostazol has been researched along with Pneumonia in 6 studies
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antiplatelet drug cilostazol decreases the risk of ischemic stroke recurrence in patients with chronic cerebral infarction." | 7.88 | Preventive Effect of Cilostazol on Pneumonia in Patients with Acute Cerebral Infarction. ( Arawaka, S; Kimura, F; Nakajima, H; Nakamura, Y; Unoda, K, 2018) |
| "We have previously reported that the phosphodiesterase inhibitor cilostazol, an antiplatelet agent, is effective and safe for secondary prevention of recurrent cerebral infarction (Cilostazol Stroke Prevention Study; CSPS)." | 7.73 | Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. ( Shinohara, Y, 2006) |
| "Cilostazol was more frequently used in the SAP(-) group (20." | 5.48 | Cilostazol is Effective to Prevent Stroke-Associated Pneumonia in Patients Receiving Tube Feeding. ( Mizuma, A; Nagata, E; Netsu, S; Sakamoto, M; Takizawa, S; Yutani, S, 2018) |
| "The antiplatelet drug cilostazol decreases the risk of ischemic stroke recurrence in patients with chronic cerebral infarction." | 3.88 | Preventive Effect of Cilostazol on Pneumonia in Patients with Acute Cerebral Infarction. ( Arawaka, S; Kimura, F; Nakajima, H; Nakamura, Y; Unoda, K, 2018) |
| "We have previously reported that the phosphodiesterase inhibitor cilostazol, an antiplatelet agent, is effective and safe for secondary prevention of recurrent cerebral infarction (Cilostazol Stroke Prevention Study; CSPS)." | 3.73 | Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. ( Shinohara, Y, 2006) |
| "Cilostazol was more frequently used in the SAP(-) group (20." | 1.48 | Cilostazol is Effective to Prevent Stroke-Associated Pneumonia in Patients Receiving Tube Feeding. ( Mizuma, A; Nagata, E; Netsu, S; Sakamoto, M; Takizawa, S; Yutani, S, 2018) |
| "Cilostazol is a potent type III phosphodiesterase inhibitor, approved as an anti-platelet aggregation agent." | 1.35 | Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model. ( Hattori, N; Miyamoto, N; Mochizuki, H; Tanaka, R; Urabe, T; Zhang, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Netsu, S | 1 |
| Mizuma, A | 1 |
| Sakamoto, M | 1 |
| Yutani, S | 1 |
| Nagata, E | 1 |
| Takizawa, S | 1 |
| Nakamura, Y | 1 |
| Nakajima, H | 1 |
| Kimura, F | 1 |
| Unoda, K | 1 |
| Arawaka, S | 1 |
| Otoshi, T | 1 |
| Kataoka, Y | 1 |
| Nakagawa, A | 1 |
| Otsuka, K | 1 |
| Tomii, K | 1 |
| Zhang, N | 1 |
| Miyamoto, N | 1 |
| Tanaka, R | 1 |
| Mochizuki, H | 1 |
| Hattori, N | 1 |
| Urabe, T | 1 |
| Shinohara, Y | 1 |
| Suzuki, K | 1 |
| Tachibana, A | 1 |
| Hatakeyama, S | 1 |
| Okano, H | 1 |
6 other studies available for cilostazol and Pneumonia
| Article | Year |
|---|---|
Cilostazol is Effective to Prevent Stroke-Associated Pneumonia in Patients Receiving Tube Feeding.
Topics: Aged; Aged, 80 and over; Cilostazol; Enteral Nutrition; Female; Humans; Male; Platelet Aggregation I | 2018 |
Preventive Effect of Cilostazol on Pneumonia in Patients with Acute Cerebral Infarction.
Topics: Acute Disease; Aged; Cerebral Infarction; Chi-Square Distribution; Cilostazol; Disability Evaluation | 2018 |
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female | 2016 |
Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model.
Topics: Animals; Bacteria; Carotid Stenosis; Chronic Disease; Cilostazol; Corpus Striatum; Cyclic AMP Respon | 2009 |
Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
Topics: Aged; Brain Ischemia; Cerebral Infarction; Chronic Disease; Cilostazol; Female; Follow-Up Studies; H | 2006 |
[A case of cilostazol-induced pneumonitis].
Topics: Aged; Cilostazol; Humans; Lung; Male; Pneumonia; Radiography; Tetrazoles | 1995 |